PDC line Pharma

At PDC*line Pharma, we are driven by a profound mission to revolutionize cancer treatment through innovative immunotherapy solutions. Founded in 2014 as a spin-off of the French Blood Bank, our commitment to advancing healthcare is rooted in a strong belief that every patient deserves access to effective and tailored therapeutic options. We specialize in developing cutting-edge cancer vaccines utilizing our proprietary plasmacytoid dendritic cell line, which empowers us to target tumors with unprecedented precision and efficacy.

Our values emphasize collaboration, integrity, and excellence. We foster a dynamic culture where creativity and scientific rigor thrive, enabling our talented team of 42 professionals to push the boundaries of biotechnology. Together, we are dedicated to addressing the complexities of cancer through our versatile and scalable immunotherapy approaches, ensuring we remain at the forefront of clinical development.

As we continue to build on our promising foundation, we invite you to join us in our mission to transform the landscape of cancer treatment. At PDC*line Pharma, we believe in the power of science to create hope and improve lives, inspiring a future where cancer is no longer an insurmountable challenge.